Deconstructing Lipid Kinase Inhibitors by Chemical Proteomics

Biochemistry. 2018 Jan 16;57(2):231-236. doi: 10.1021/acs.biochem.7b00962. Epub 2017 Nov 22.

Abstract

Diacylglycerol kinases (DGKs) regulate lipid metabolism and cell signaling through ATP-dependent phosphorylation of diacylglycerol to biosynthesize phosphatidic acid. Selective chemical probes for studying DGKs are currently lacking and are needed to annotate isoform-specific functions of these elusive lipid kinases. Previously, we explored fragment-based approaches to discover a core fragment of DGK-α (DGKα) inhibitors responsible for selective binding to the DGKα active site. Here, we utilize quantitative chemical proteomics to deconstruct widely used DGKα inhibitors to identify structural regions mediating off-target activity. We tested the activity of a fragment (RLM001) derived from a nucleotide-like region found in the DGKα inhibitors R59022 and ritanserin and discovered that RLM001 mimics ATP in its ability to broadly compete at ATP-binding sites of DGKα as well as >60 native ATP-binding proteins (kinases and ATPases) detected in cell proteomes. Equipotent inhibition of activity-based probe labeling by RLM001 supports a contiguous ligand-binding site composed of C1, DAGKc, and DAGKa domains in the DGKα active site. Given the lack of available crystal structures of DGKs, our studies highlight the utility of chemical proteomics in revealing active-site features of lipid kinases to enable development of inhibitors with enhanced selectivity against the human proteome.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adenosine Triphosphate / metabolism
  • Amino Acid Sequence
  • Diacylglycerol Kinase / antagonists & inhibitors*
  • Diacylglycerol Kinase / metabolism
  • Dose-Response Relationship, Drug
  • Drug Design
  • Enzyme Inhibitors / chemistry*
  • Molecular Structure
  • Proteomics / methods*
  • Recombinant Proteins / metabolism
  • Ritanserin / analogs & derivatives*
  • Ritanserin / chemistry
  • Ritanserin / metabolism
  • Ritanserin / pharmacology
  • Structure-Activity Relationship

Substances

  • Enzyme Inhibitors
  • RLM001
  • Recombinant Proteins
  • Ritanserin
  • Adenosine Triphosphate
  • Diacylglycerol Kinase